Brind.

Arrowhead Pharmaceuticals and Bayer are navigating the post-tariff future of clinical trials, discussing supply chains on the US West Coast.

1 report, 1 independent Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Arrowhead Pharmaceuticals and Bayer are navigating the post-tariff future of clinical trials, discussing supply chains on the US West Coast.

Who's involved

What this event is mainly about
Arrowhead PharmaceuticalsBAYER

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Clinical Trials ArenaClinical trial supply chains in the US navigate pharma tariffs Tariffs imposed by President Trump on US pharma imports have left experts charting a new course for the nation’s clinical trials industr